ArticleBriefings in bioinformatics2025
scVGAMF: a novel imputation method for scRNA-seq data by integrating linear and non-linear features.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Cell and Spatial Omics: Methods and Applications.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Single-cell RNA sequencing (scRNA-seq) is crucial for elucidating gene expression dynamics and cellular heterogeneity at the individual cell level, thereby advancing our understanding of transcriptional regulation across distinct cell populations. However, a significant challenge in scRNA-seq data analysis is the prevalence of dropout events, which complicate downstream analyses. Most existing imputation tools either rely solely on linear assumptions or overlook the non-linear regulatory relationships embedded in the data. To address this issue, we propose single-cell variational graph autoencoder and matrix factorization (scVGAMF), a novel imputation method that integrates both linear and non-linear features. Specifically, scVGAMF first identifies highly variable genes and partitions them into groups. Cells are then clustered by applying spectral clustering to the principal component analysis results of the representative groups. Based on the resulting submatrices, along with the gene similarity and cell-cell similarity matrices, scVGAMF employs non-negative matrix factorization to extract underlying linear features while utilizing two variational graph autoencoders to capture non-linear features. A fully connected neural network then integrates these features to predict missing values. Extensive experimental evaluations on simulated dropout datasets and real scRNA-seq data demonstrate that scVGAMF outperforms existing methods in gene expression recovery, cell clustering accuracy, differential gene identification, and pseudo-trajectory analysis. Furthermore, ablation studies confirm that the integration of both linear and non-linear features significantly enhances overall data imputation performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.